It is noted that astrocytic GLT‐1 (SLC1A2) deficiency caused mDA neuron death and PD symptoms (Zhang et al, 2020), while increased GLT‐1 expression has also been shown to have beneficial and therapeutic effects (Kobayashi et al, 2018). Here, SLC1A2 is linked to Parkinson disease.